Journal of Tongji Medical University

, Volume 21, Issue 3, pp 228–230 | Cite as

Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma

  • Chen Libo
  • Yang Zhen
  • Wang Guobin
  • Wang Chunyou
Article

Summary

To explore the relationship of angiogenesis-related angiopoietin-2 gene and its receptor Tie2 with angiogenesis and the biology, of hepatocellular carcinoma (HOC), angiopoietin-2 gene, Tie2 and CD34 protein expression in 22 resected HOC, 8 cirrhotic and 8 control liver specimens were investigated byin situ hybridization and immunohistochemistry respectively, and the level of angiopoietin-2 and Tie2 expression in HCC were compared in terms of tumor biological parameters. It was found that CD34 was not expressed in control liver, expressed scarcely in cirrhotic liver (17. 8±13.5/HP), but intensively expressed in HCC (86. 3±34. 8/HP,P<0.01). Tie2 receptor was not expressed in controls, expressed at low level in cirrhotic liver (11. 3±8.7/HP), while strongly positive in the microvascular endothelia of HCC (52. 4±16. 7/HP,P<0.01). The level of Tie2 receptor expression in HCC was closely related with tumor diameter, angiogenesis and portal invasion. Angiopoietin-2 gene was not expressed in control liver, expressed mildly in cirrhotic liver (11.2±9. 7/HP), but extensively in tumor zone (36. 4±17. 5/HP), the level of angiopoietin-2 expression was closely related with angiogenesis, portal invasion and histological grading of HCC. It is concluded that angiogenesis is increased in HCC; angiopoietin-2/Tie2 expression in human hepatic carcinoma is closely related with angiogenesis, which are probably involved in the HCC angiogenesis regulation, promoting the development and metastasis of human hepatic cancer.

Key words

angiopoietin-2 Tie2 receptor angiogenesis carcinoma hepatocellular 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Folkman J. Tumor angiogenesis: therapeutic implication. New England J Med, 1971,285:1182Google Scholar
  2. 2.
    Torimura T, Sata M, Ueno Tet al. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Human Pathol, 1998,29:986CrossRefGoogle Scholar
  3. 3.
    Santo T, Yozawa Y, Deutsch Uet al. Distinct roles of the tyrosine kinase receptors Tie-1 and Tie-2 in blood vessel formation. Nature, 1995,376:70CrossRefGoogle Scholar
  4. 4.
    Peters K G, Coogan A, Berry Det al. Expression of Tie2/Tek in breast tumor vasculature provides a new marker for evaluation of tumor angiogenesis. Br J Cancer, 1998,77:51PubMedGoogle Scholar
  5. 5.
    Siemeister G, Schirner M, Weindel Ket al. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melonoma xenograft growth by interfering with either the vascular endothelial growth fac(Continuted from page 230) tor receptor pathway or the Tie2 pathway. Cancer Res, 1999,59:3185PubMedGoogle Scholar
  6. 6.
    Davis S, Aldrich T H, Jones P Fet al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 1996,87:1161PubMedCrossRefGoogle Scholar
  7. 7.
    Maisonpierre P C, Suri C, Jones P Fet al. Angiopoietin-2, a natiral antagonist for Tie2 that disruptsin vivo angiogenesis. Science, 1997,277:55PubMedCrossRefGoogle Scholar
  8. 8.
    Stratmann A, Risau W, Plate K H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol, 1998, 153:1459PubMedGoogle Scholar
  9. 9.
    Tanaka S, Mori M, Sakamoto Yet al. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest, 1999,103:341PubMedCrossRefGoogle Scholar
  10. 10.
    Lin P, Buxton J A, Acheson Aet al. Antiangiogeneic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci USA, 1998, 95:8829PubMedCrossRefGoogle Scholar
  11. 11.
    Takahama M, Tsutsumi M, Tsujiuchi Tet al. Enhanced expression of Tie2, its ligand Angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung cancer. Clin Cancer Res, 1999, 5:2506PubMedGoogle Scholar
  12. 12.
    Holash J, Maisonpierre P C, Compton Det al. Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF. Science, 1999,284:1994PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2001

Authors and Affiliations

  • Chen Libo
    • 1
  • Yang Zhen
    • 1
    • 2
  • Wang Guobin
    • 1
  • Wang Chunyou
    • 1
  1. 1.Department of General Surgery, Xiehe Hospital, Tongji Medical SchoolHuazhong University of Science and TechnologyWuhan
  2. 2.Department of General Surgery, Tongji Hospital, Tongji Medical SchoolHuazhong University of Science and TechnologyWuhan

Personalised recommendations